Prostate Cancer
Optimal assessment of quality of life for patients with prostate cancer.
December 21, 2022
The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer.
December 21, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
December 21, 2022
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
December 20, 2022
Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome.
December 20, 2022
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.
December 20, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
December 20, 2022
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy.
December 19, 2022
Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
December 19, 2022
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
December 19, 2022
Salvage irreversible electroporation for radio recurrent prostate cancer - The prospective FIRE trial.
December 16, 2022